Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
Plos Computational Biology|October 2, 2018
Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine designAndreas Handel, Yan Li, Brian McKay, et al.Journal of Theoretical Biology|April 26, 2003
Models of CD8+ responses: 1. What is the antigen-independent proliferation programRustom Antia, Carl T Bergstrom, Sergei S Pilyugin, et al.Journal of Theoretical Biology|October 25, 2003
The rescaling method for quantifying the turnover of cell populationsSergei S Pilyugin, Vitaly V Ganusov, Kaja Murali-Krishna, et al.Immunity|November 29, 2025
Quantifying the waning of humoral immunityAnanya Saha, Hasan Ahmed, Cora Hirst, et al.Journal of the Royal Society, Interface|August 26, 2011
The global spread of drug-resistant influenzaDennis L Chao, Jesse D Bloom, Beth F Kochin, et al.Expert Review of Vaccines|February 19, 2024
Recombinant transmissible vaccines will be intrinsically contained despite the ability to superinfectJames J Bull, Scott L Nuismer, Christopher H Remien, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 22, 2015
Masking of antigenic epitopes by antibodies shapes the humoral immune response to influenzaVeronika I Zarnitsyna, Ali H Ellebedy, Carl Davis, et al.Bulletin of Mathematical Biology|March 4, 2020
Varying Inoculum Dose to Assess the Roles of the Immune Response and Target Cell Depletion by the Pathogen in Control of Acute Viral InfectionsJames R Moore, Hasan Ahmed, Balaji Manicassamy, et al.Frontiers in Immunology|October 20, 2022
Vaccine models predict rules for updating vaccines against evolving pathogens such as SARS-CoV-2 and influenza in the context of pre-existing immunityRajat Desikan, Susanne L Linderman, Carl Davis, et al.Plos One|December 13, 2007
Revisiting estimates of CTL killing rates in vivoAndrew Yates, Frederik Graw, Daniel L Barber, et al.Pageof 12